T500-1518 Screening compound: 1-{1-oxa-9-azaspiro[5.5]undecan-9-yl}-4-(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)butane-1,4-dione

T500-1518 Screening compound: 1-{1-oxa-9-azaspiro[5.5]undecan-9-yl}-4-(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)butane-1,4-dione
T500-1518 Screening compound: 1-{1-oxa-9-azaspiro[5.5]undecan-9-yl}-4-(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)butane-1,4-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound T500-1518
1-{1-oxa-9-azaspiro[5.5]undecan-9-yl}-4-(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)butane-1,4-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T500-1518

Molecular Formula

C21H27N3O4 (C21 H27 N3 O4)

Compound Name

1-{1-oxa-9-azaspiro[5.5]undecan-9-yl}-4-(3-oxo-1,2,3,4-tetrahydroquinoxalin-1-yl)butane-1,4-dione

IUPAC name

1-{1-oxa-9-azaspiro[5.5]undecan-9-yl}-4-(3-oxo-1234-tetrahydroquinoxalin-1-yl)butane-14-dione

SMILES

O=C(CCC(N(C1)c(cccc2)c2NC1=O)=O)N(CC1)CCC11OCCCC1

InChI

InChI=1S/C21H27N3O4/c25-18-15-24(17-6-2-1-5-16(17)22-18)20(27)8-7-19(26)23-12-10-21(11-13-23)9-3-4-14-28-21/h1-2,5-6H,3-4,7-15H2,(H,22,25)

InChI Key

AQZMNLIKHIJVNY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29016433

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

385.46

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.069

Distribution Coefficient, logD

1.068

Water Solubility, LogSw

-2.21

Polar Surface Area

62.852

Acid Dissociation Constant (pKa)

9.91

Base Dissociation Constant (pKb)

6.01

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.10

T500-1518 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with T500-1518 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T500-1518?
Check Price and Availability of T500-1518, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T500-1518 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T500-1518
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T500-1518
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T500-1518 available by request